NeuroOne Medical Technologies Corporation (NMTC) Financial Statements (2024 and earlier)

Company Profile

Business Address 7599 ANAGRAM DR
EDEN PRAIRIE, MN 55344
State of Incorp. DE
Fiscal Year End September 30
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,3223,0834,5987,64311,14110,178
Cash and cash equivalents5,3223,0833,6024,6678,16010,178
Short-term investments   9952,9752,981 
Receivables  2149533 
Inventory, net of allowances, customer advances and progress billings1,7271,5171,174904705454
Inventory1,7271,5171,174904705454
Prepaid expense264279371325297297
Other current assets      
Total current assets:7,3134,8796,3578,96712,17610,929
Noncurrent Assets
Operating lease, right-of-use asset169197225252181209
Property, plant and equipment526587523335354315
Intangible assets, net (including goodwill)9095101106112117
Intangible assets, net (excluding goodwill)9095101106112117
Total noncurrent assets:784879849693647642
TOTAL ASSETS:8,0975,7587,2059,66012,82311,571
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7931,7481,5501,3352,165812
Employee-related liabilities521
Accounts payable685959953862928325
Accrued liabilities1,108789597473716487
Other undisclosed current liabilities     9342
Total current liabilities:1,7931,7481,5501,3353,099815
Noncurrent Liabilities
Long-term debt and lease obligation:     120138
Liabilities, other than long-term debt5589122154  
Operating lease, liability5589122154120138
Other undisclosed noncurrent liabilities     (120)(138)
Total noncurrent liabilities:5589122154 138
Total liabilities:1,8481,8371,6721,4883,218952
Equity
Equity, attributable to parent6,2493,9215,5338,1729,60410,618
Common stock241817161616
Additional paid in capital68,91263,45561,59860,71560,41560,055
Accumulated deficit(62,686)(59,551)(56,082)(52,560)(50,827)(49,452)
Total equity:6,2493,9215,5338,1729,60410,618
TOTAL LIABILITIES AND EQUITY:8,0975,7587,2059,66012,82311,571

Income Statement (P&L) ($ in thousands)

12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
Revenues7426304661156932
Other income  41(27)52262
Cost of revenue(548)(386)(435)(127)(84)(38)
Gross profit:19424432(12)(15)(6)
Operating expenses(3,358)(3,754)(3,527)(3,227)(3,328)(2,755)
Other undisclosed operating income    1,4551,942 
Operating loss:(3,165)(3,510)(3,496)(1,784)(1,400)(2,761)
Nonoperating income
(Other Nonoperating income)
      
Other undisclosed income from continuing operations before equity method investments, income taxes 96     
Loss from continuing operations before equity method investments, income taxes:(3,069)(3,510)(3,496)(1,784)(1,400)(2,761)
Other undisclosed income (loss) from continuing operations before income taxes (66)41(27)52(5)2
Loss from continuing operations:(3,135)(3,469)(3,523)(1,733)(1,405)(2,760)
Loss before gain (loss) on sale of properties:(1,405)(2,760)
Net loss:(3,135)(3,469)(3,523)(1,733)(1,405)(2,760)
Other undisclosed net income attributable to parent     31 
Net loss available to common stockholders, diluted:(3,135)(3,469)(3,523)(1,733)(1,374)(2,760)

Comprehensive Income ($ in thousands)

12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
Net loss:(3,135)(3,469)(3,523)(1,733)(1,405)(2,760)
Comprehensive loss, net of tax, attributable to parent:(3,135)(3,469)(3,523)(1,733)(1,405)(2,760)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: